NCT03278782 2026-01-09Study of Pembrolizumab (MK-3475) in Combination With RomidepsinM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting39 enrolled
NCT03011814 2025-09-18Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaCity of Hope Medical CenterPhase 1/2 Active not recruiting38 enrolled